Trials / Withdrawn
WithdrawnNCT01926301
Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy
Cerebrovascular Autoregulation in Patients With Severe Sepsis and Septic Shock, Influence of Renal Replacement Therapy
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Johannes Gutenberg University Mainz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The cerebrovascular autoregulation is impaired in patients with severe sepsis and septic shock. A continuous veno-venous hemodialysis may improve impaired cerebrovascular autoregulation. Hypothesis: continuous hemodialysis recovers impaired cerebrovascular autoregulation in patients with acute severe sepsis and septic shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | continuous veno-venous hemodialysis |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2013-08-20
- Last updated
- 2020-06-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01926301. Inclusion in this directory is not an endorsement.